Endpoints News Executive Editor Drew Armstrong leads a conversation on China biopharma at the Financial Times summit, with Susan Winckler, CEO of the Reagan-Udall Foundation for the FDA, and Caitlin Frazer, executive director of the National Security Commission on Emerging Biotechnology (courtesy of The Financial Times)

May 20, 2026 01:44 PM EDT

Post-Hoc: The next big phar­ma com­pa­ny will come from Chi­na

Last week at our bio­phar­ma and health­care sum­mit with the Fi­nan­cial Times, I was asked dur­ing one of our breaks when we’ll see the first …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.